OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,600 | +17.1% | 2,500,000 | 0.0% | 0.41% | +62.2% |
| Q2 2023 | $8,200 | +27.1% | 2,500,000 | 0.0% | 0.25% | -33.7% |
| Q1 2023 | $6,450 | +38.7% | 2,500,000 | 0.0% | 0.38% | +47.3% |
| Q4 2022 | $4,650 | -99.9% | 2,500,000 | 0.0% | 0.26% | +32.7% |
| Q3 2022 | $4,600,000 | -14.4% | 2,500,000 | 0.0% | 0.20% | -31.7% |
| Q2 2022 | $5,375,000 | -31.5% | 2,500,000 | 0.0% | 0.29% | -12.8% |
| Q1 2022 | $7,850,000 | -2.2% | 2,500,000 | 0.0% | 0.33% | +50.9% |
| Q4 2021 | $8,025,000 | -4.5% | 2,500,000 | 0.0% | 0.22% | +16.0% |
| Q3 2021 | $8,400,000 | -14.1% | 2,500,000 | 0.0% | 0.19% | -5.1% |
| Q2 2021 | $9,775,000 | -2.7% | 2,500,000 | 0.0% | 0.20% | +11.2% |
| Q1 2021 | $10,050,000 | +74.0% | 2,500,000 | 0.0% | 0.18% | +43.5% |
| Q4 2020 | $5,775,000 | -59.8% | 2,500,000 | 0.0% | 0.12% | -64.4% |
| Q3 2020 | $14,350,000 | – | 2,500,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |